Lu Huaqing相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Combination of Vaccine With IL-12-Armed Oncolytic Virus SKV-012 Synergistically Potentiates Immune Responses in HPV-Associated Malignancies

疫苗与IL-12武装溶瘤病毒SKV-012联合使用可协同增强HPV相关恶性肿瘤的免疫反应。

影响因子:10.7

doi:10.1002/mco2.70737

Yang, Nian; Xu, Long; Zheng, Meijun; Lu, Huaqing; Chen, Yongdong; Zhu, Zhixiong; Zeng, Wanqin; Wang, Zeng; Li, Hexian; Li, Jia; Jiang, Zheng; Zeng, Pingfu; Wang, Guoqing; Xie, Hai; Zhang, Zongliang; Yang, Hui; Tong, Aiping

免疫/内分泌

发表日期：2026

文献求助收藏

YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma

YMN-V115：一种用于治疗复发/难治性多发性骨髓瘤的新型人源化BCMA/GPRC5D/CD3三特异性抗体

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2025-013986

Li, Jia; Lu, Qizhong; Zhu, Zhixiong; Wang, Xuehui; Chen, Yangji; Zhang, Zongliang; Yu, Zhengyu; Wang, Zeng; Chen, Yongdong; Xie, Hai; Yang, Nian; Lu, Huaqing; Niu, Ting; Nie, Chunlai; Tong, Aiping; Li, Hexian

多发性骨髓瘤

发表日期：2026

文献求助收藏

CRISPR/Cas9-engineered universal CD123/B7-H3 tandem CAR-T cell for the treatment of acute myeloid leukemia.

利用 CRISPR/Cas9 技术改造的通用 CD123/B7-H3 串联 CAR-T 细胞用于治疗急性髓系白血病。

期刊:Chinese Medical Journal

影响因子:7.3

doi:10.1097/CM9.0000000000003588

Li Hexian, Lu Qizhong, Yu Zhengyu, Wu Zhiguo, Zhu Zhixiong, Li Jia, Zhang Zongliang, Wang Zeng, Yang Nian, Chen Yongdong, Lu Huaqing, Niu Ting, Tong Aiping

细胞生物学

发表日期：2026

文献求助收藏

Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors.

对表达IL-12的SKV-012溶瘤病毒进行瘤内注射治疗晚期实体瘤的临床前和临床评价

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2025-011642

Jiang Zheng, Yang Nian, Jin Jing, Zhang Zongliang, Lu Huaqing, Xu Long, Chen Yongdong, Jin Liyuan, Zhou Liangxue, Yang Hui, Liu Jun, Zhang Weiwei, Tong Aiping, Peng Xingchen

发表日期：2025

文献求助收藏

A novel immunocytokine promotes T cell- and cytokine-induced killer cell-mediated antitumor immunity via a non-MHC-restricted mechanism in glioblastoma.

一种新型免疫细胞因子通过非 MHC 限制性机制促进胶质母细胞瘤中 T 细胞和细胞因子诱导的杀伤细胞介导的抗肿瘤免疫。

期刊:Journal of Translational Medicine

影响因子:7.5

doi:10.1186/s12967-025-07321-5

Zhang Xiaoke, Yang Nian, Tang Xin, Liu Nanxi, Lu Qizhong, Zhang Zongliang, Xu Long, Jiang Lu, Ge Honglin, Lu Huaqing, Chen Yongdong, Bao Mingbin, Tong Aiping, Zhou Liangxue

细胞生物学

发表日期：2025

文献求助收藏

mRNA-Engineered CD5-CAR-γδT(CD5-) Cells for the Immunotherapy of T-Cell Acute Lymphoblastic Leukemia

mRNA工程化CD5-CAR-γδT(CD5-)细胞用于T细胞急性淋巴细胞白血病的免疫治疗

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202400024

Zhu, Zhixiong; Li, Hexian; Lu, Qizhong; Zhang, Zongliang; Li, Jia; Wang, Zeng; Yang, Nian; Yu, Zhengyu; Yang, Chen; Chen, Yongdong; Lu, Huaqing; Wang, Wei; Niu, Ting; Nie, Chunlai; Tong, Aiping

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy

利用CAR-T细胞进行溶瘤疱疹病毒的系统性递送可增强抗肿瘤免疫病毒疗法的靶向性。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-024-03757-8

Zhang, Zongliang; Yang, Nian; Xu, Long; Lu, Huaqing; Chen, Yongdong; Wang, Zeng; Lu, Qizhong; Zhong, Kunhong; Zhu, Zhixiong; Wang, Guoqing; Li, Hexian; Zheng, Meijun; Zhou, Liangxue; Tong, Aiping

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Iron-based and BRD4-downregulated strategy for amplified ferroptosis based on pH-sensitive/NIR-II-boosted nano-matchbox

基于 pH 敏感/NIR-II 增强纳米火柴盒的铁基和 BRD4 下调扩增铁死亡策略

期刊:Acta Pharmaceutica Sinica B

影响因子:14.7

doi:10.1016/j.apsb.2022.05.011

Lujing Geng, Tong Lu, Huaqing Jing, Yue Zhou, Xiaoyang Liang, Jiao Li, Nan Li

细胞生物学

发表日期：2023

文献求助收藏

Development of an autophagy activator from Class III PI3K complexes, Tat-BECN1 peptide: Mechanisms and applications

从III类PI3K复合物中开发自噬激活剂Tat-BECN1肽：机制和应用

期刊:Frontiers in Cell and Developmental Biology

影响因子:4.3

doi:10.3389/fcell.2022.851166

He, Yanfei; Lu, Huaqing; Zhao, Yuting

发表日期：2022

文献求助收藏